Works matching IS 03009564 AND DT 2020 AND VI 127 AND IP 2

Results: 20

Genes to treat excitotoxicity ameliorate the symptoms of the disease in mice models of multiple system atrophy.

Published in:

Journal of Neural Transmission, 2020, v. 127, n. 2, p. 205, doi. 10.1007/s00702-020-02158-2

By:

Glat, Micaela Johanna;
Stefanova, Nadia;
Wenning, Gregor Karl;
Offen, Daniel

Publication type:

Article

Prof. Dr. Moussa B.H. Youdim: an appreciation on the occasion of his 80th birthday.

Published in:

2020

By:

Riederer, Peter

Publication type:

Editorial

The discovery and development of rasagiline as a new anti-Parkinson medication.

Published in:

Journal of Neural Transmission, 2020, v. 127, n. 2, p. 125, doi. 10.1007/s00702-020-02142-w

By:

Finberg, John P. M.

Publication type:

Article

A platinum black-modified microelectrode for in situ olanzapine detection in microliter volumes of undiluted serum.

Published in:

Journal of Neural Transmission, 2020, v. 127, n. 2, p. 291, doi. 10.1007/s00702-019-02139-0

By:

Shukla, Rajendra P.;
Belmaker, Robert H.;
Bersudsky, Yuly;
Ben-Yoav, Hadar

Publication type:

Article

Microbiota changes associated with ADNP deficiencies: rapid indicators for NAP (CP201) treatment of the ADNP syndrome and beyond.

Published in:

Journal of Neural Transmission, 2020, v. 127, n. 2, p. 251, doi. 10.1007/s00702-020-02155-5

By:

Kapitansky, Oxana;
Giladi, Eliezer;
Jaljuli, Iman;
Bereswill, Stefan;
Heimesaat, Markus M.;
Gozes, Illana

Publication type:

Article

FG 7142: is this validated tool to study anxiety now forgotten?

Published in:

Journal of Neural Transmission, 2020, v. 127, n. 2, p. 287, doi. 10.1007/s00702-019-02136-3

By:

Horowski, R.

Publication type:

Article

Microglia and Parkinson's disease: footprints to pathology.

Published in:

2020

By:

Lazdon, Ekaterina;
Stolero, Nofar;
Frenkel, Dan

Publication type:

Literature Review

Parkinson's disease and iron.

Published in:

2020

By:

Mochizuki, Hideki;
Choong, Chi-Jing;
Baba, Kousuke

Publication type:

Literature Review

Different response to instrumental tests in relation to cognitive demand after dopaminergic stimulation in previously treated patients with Parkinson's disease.

Published in:

Journal of Neural Transmission, 2020, v. 127, n. 2, p. 265, doi. 10.1007/s00702-020-02148-4

By:

Müller, Thomas;
Harati, Ali

Publication type:

Article

Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease.

Published in:

2020

By:

Barilar, Jelena Osmanovic;
Knezovic, Ana;
Perhoc, Ana Babic;
Homolak, Jan;
Riederer, Peter;
Salkovic-Petrisic, Melita

Publication type:

Literature Review

Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson's disease.

Published in:

Journal of Neural Transmission, 2020, v. 127, n. 2, p. 131, doi. 10.1007/s00702-020-02150-w

By:

Naoi, Makoto;
Maruyama, Wakako;
Shamoto-Nagai, Masayo

Publication type:

Article

The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson's disease and in schizophrenia.

Published in:

2020

By:

Ben-Shachar, Dorit

Publication type:

Literature Review

Ted Sourkes, Moussa Youdim and I.

Published in:

Journal of Neural Transmission, 2020, v. 127, n. 2, p. 119, doi. 10.1007/s00702-019-02135-4

By:

Cuello, A. Claudio

Publication type:

Article

Correction to: Hypothesis: neural mechanism of psychotherapy for the treatment of Parkinson's disease: cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy?

Published in:

2020

By:

Nagatsu, Toshiharu

Publication type:

Correction Notice

Cannabinoid1 (CB-1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose.

Published in:

Journal of Neural Transmission, 2020, v. 127, n. 2, p. 279, doi. 10.1007/s00702-019-02132-7

By:

Skolnick, Phil;
Crystal, Roger

Publication type:

Article

Correction to: The catecholaldehyde hypothesis: where MAO fits in.

Published in:

2020

By:

Goldstein, David S.

Publication type:

Correction Notice

Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.

Published in:

Journal of Neural Transmission, 2020, v. 127, n. 2, p. 189, doi. 10.1007/s00702-019-02138-1

By:

Devos, David;
Cabantchik, Z. Ioav;
Moreau, Caroline;
Danel, Véronique;
Mahoney-Sanchez, Laura;
Bouchaoui, Hind;
Gouel, Flore;
Rolland, Anne-Sophie;
Duce, James A.;
Devedjian, Jean-Christophe;
The FAIRPARK-II and FAIRALS-II studygroups;
Cassereau, Julien;
Bost, Marie;
Abrial, Charlotte;
Muller, Jeanne;
Olivier, Audrey;
Le Masson, Gwendal;
Mathis, Stéphane;
Djigo, Dieynaba;
Bonabaud, Sarah

Publication type:

Article

6-Hydroxydopamine: a far from simple neurotoxin.

Published in:

Journal of Neural Transmission, 2020, v. 127, n. 2, p. 213, doi. 10.1007/s00702-019-02133-6

By:

Varešlija, Damir;
Tipton, Keith F.;
Davey, Gavin P.;
McDonald, Andrew G.

Publication type:

Article

Hypothesis: neural mechanism of psychotherapy for the treatment of Parkinson's disease: cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy?

Published in:

Journal of Neural Transmission, 2020, v. 127, n. 2, p. 273, doi. 10.1007/s00702-019-02111-y

By:

Nagatsu, Toshiharu

Publication type:

Article

The catecholaldehyde hypothesis: where MAO fits in.

Published in:

Journal of Neural Transmission, 2020, v. 127, n. 2, p. 169, doi. 10.1007/s00702-019-02106-9

By:

Goldstein, David S.

Publication type:

Article